Cancer Research UK

In 2013 CRUK and NCRAS established a partnership to conduct analysis that both organisations see as a priority. This includes but is not limited to:

• understanding the cancer pathway better and timeliness of patients receiving treatment  
• increasing our understanding of survival in cancer patients  
• analysing cancer outcomes from diagnosis through treatment
• investigating inequalities across the cancer pathway 

The partnership has contributed to many outputs over the years, with some highlighted and linked to below. 

Latest publication - 1- and 5- year conditional survival

The partnership team have calculated conditional 1- and 5- year survival estimates for patients diagnosed in England between 2015 and 2019. This analysis calculates the survival of patients who have already survived their diagnosis for at least 1, 3, 6 or 12 months. Breakdowns are presented for 14 cancer sites and additionally by gender, stage, age and deprivation quintile. Read the full report on the CRUK website

Previous publications

• A comparative analysis of the National Cancer Diagnosis Audit for England 2018 vs 2014
• 10 year survival by stage for the East of England*
• Oral Etoposide as a single agent in childhood and young adult cancer
• Calculating the Secondary Diagnostic Interval for patients in England
• Relationship between ethnicity and stage at diagnosis in England
• Estimating surgery, radiotherapy and systemic anti-cancer therapy treatment costs for cancer patients by stage at diagnosis
• Cross sectional study using primary care and cancer registration data to investigate patients with cancer presenting with non-specific symptoms
• Which cancer patients experience long waits to treatment, and why?
• Concordance to colon and non-small cell lung cancer NICE treatment guideline recommendations

*Please note this is a historic project so there may be some differences with the more recent methodologies used by NDRS

For more information, please contact [email protected]